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Summary: Increased sodium-lithium countertransport in erythrocytes from patients with long-standing type I (insu-
lin-dependent) diabetes mellitus has been considered as an early marker of nephropathy. Since the activity and
kinetics of the sodium-lithium countertransport may critically depend on loading conditions, this study was aimed
at determining sodium-lithium countertransport activity, Michaelis constant Km and maximum velocity Kmax in
erythrocytes loaded in two different Li4" solutions. Sodium-lithium countertransport activity was determined in
erythrocytes in 8 healthy control subjects after loading with 150 mmol/1 LiCl compared with those loaded with 150
mmol/1 LiHCO3. Sodium-lithium countertransport activity was similar for both loading procedures, although the
erythrocyte lithium content did significantly differ (mean ± SEM, 7.0 ± 0.5 for LiCl and 8.9 ± 0.5 mmol/1 of cells
for 150 mmol/1 LiHCO3). There were no significant changes in the Km and Fmax. Increase of osmolality in efflux
media containing 200 and 250 mmol/1 NaCl resulted in a negligible shrinking of the red blood cells, not exceed-
ing 2.2%.
The main advantage is the short loading time of 15 min for LiHCO3 compared with 3 hours for LiCl. Under these
conditions saturating intracellular Li"1" concentrations can be obtained much more rapidly than with LiCl loading,
thereby minimising alterations of the cell membranes. LiHCO3 loading shortens the experimental time considerably
and enables a greater number of samples to be screened from larger population cohorts.
Introduction Km with no difference in Fmax, as compared with normo-
τ^ , , , ~ . j j· tensive subjects. Possibly, these discrepancies mayThere have been several reports of increased sodium- , J „^ j9 , . , . J
r A- + - * - - - · - * /or ^\ · *· * vu ^ ι partly be due to different assay methodologies or to se-lithium countertransport (SLC) m patients with essential * .J . J
hypertension (1,2) and insulin-dependent diabetes with
and without micrpalbuminuria (3-5). This sodium-lith- Thus, the aim of this study was to validate the sodium-
ium countertransport system exchanges *Li+ for Na+ in lithium countertransport measurements and to assess the
an external Na+-stimulated Li+ efflux, and it shows sat^ influence of different loading media on the countertrans-
uration according to Michaelis-Menten kinetics (6). An port activity and its kinetics.
elevated sodium-lithium countertransport activity in
erythrocytes has been found in hypertensive subpopul-
ations (1) and in patients with insulin-dependent diabetes Materials and Methods
mellitus complicated by renal disease (7, 8), but not in Λ . _ J 1t. , . . , . . - j r-t ^ · /™ τ Preparation of red cell suspensionindividuals with secondary cause of hypertension (9). In
contrast, Rutherford et al. have reported (10) that the Venous blood from 8 non-fasted healthy volunteers (age: 25 ±4
, . . j j. ,.,.· \- ·*. · years> mean ± SD) was collected between 7.00-8.00 a.m., usingelevated sodium-lithium countertransport activity in pa- Μοηονβ«β® syringes (Sarstedt, Numbrecht, Germany) containing
tients with essential hypertension is attributable to a low EDTA, and centrifuged at 1500 g. The red cells were washed four
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times with an isoosmotic washing b ffer (75 mmol/1 magnesium
chloride/80 mmol/1 sucrose/5 mmol/1 glucose/10 mmol/1 tris(hy-
dΓOxymethyl)aminomethane-moφholino-propane sulphonic acid
[Tris-MOPS], pH 7.55) at 20 °C. Osmolality was measured using
a Knauer automatic semi-micro osmometer A300. Red cell suspen-
sions were kept at room temperature and used within one hour.
Sodium-l i th ium countertransport activity -
comparison of methods
Measurement of sodium-lithium countertransport after loading
with lithium chloride
The method used was similar to that described by Canessa et al.
(1). Four millilitres of washed red cells were incubated for three
hours at 37 °C with shaking in 20 ml loading solution (150 mmol/1
lithium chloride/10 mmol/1 glucose/10 mmol/1 Tris-MOPS, pH
7.55). The cells were washed five times with washing buffer to
remove the extracellular lithium. An aliquot of the lithium-loaded
cells was taken for determination of haematocrit, haemoglobin and
the lithium content of the haemolysed cells by atomic absorption
spectrometry (UNICAM Model Solaar 939). The lithium efflux
was measured by incubating 1.8 ml of cell suspension (haematocrit
0.05—0.08) in a sodium-free medium and in a sodium medium as
described in detail (11). After 0, 30, 60 and 90 minutes, incubation
in either medium was stopped by cooling the tubes on ice for two
minutes and subsequent centrifugation at 1500 g for four minutes
at 4 °C. Lithium concentration in the supernatant was measured by
atomic absorption spectrophotometry. Sodium-lithium counter-
transport activity was determined as the difference between the
sodium-stimulated lithium efflux and the passive efflux in potas-
sium chloride medium over time.
The intra-assay variation of our assay is 7.7% (n = 9) and the inter-
assay variation is 15.3% (n = 4), where the inter-assay variation
expresses both the variability of the test and the biological variabil-
ity by measuring 4 samples during a four week period in five in-
dividuals. These assay variations are comparable to those reported
in the literature (3, 5).
Measurement of sodium-lithium countertransport after loading
with lithium bicarbonate
This method was carried out by the same procedure as described
above except for the loading conditions. Instead of a lithium chlo-
ride solution, the erythrocytes were incubated in a lithium bicar-
bonate medium (150 mmol/1 lithium bicarbonate/10 mmol/1 glu-
cose/10 mmol/1 Tris-MOPS gassed with CO2 until the pH value
had adjusted to 7.55) according to Ibsen et al. (12) for 15 min.
Thereafter the cells were washed five times and the efflux measure-
ments were performed as mentioned above. Sodium-lithium
countertransport values obtained with both methods were com-
pared in 8 healthy subjects.
Km and Vmax of sodium-lithium countertransport
Erythrocytes were loaded with 150 mmol/1 lithium chloride or 150
mmol/1 lithium bicarbonate. The erythrocytes were then incubated
in media containing 0, 50, 100, 150, 200 and 250 mmol/1 NaCl,
respectively. The media also contained 1 mmol/1 MgCl2/10 mmol/1
glucose/0.1 mmol/1 ouabain/10 mmol/1 Tris-MOPS, pH 7.55. The
solutions containing < 100 mmol/1 NaCl were made isotonic with
potassium chloride according to Ibsen et al. (12) who found iden-
tical values for leak efflux in KC1 medium and in media used in
other laboratories such as cholinium chloride or magnesium chlo-
ride.
The Michaelis constant Km and maximum velocity >max were cal-
culated by non-linear regression of the Michaelis-Menten equation
v - ^rnax [S]/(tfm + [S]) using the Marquardt-Levenberg algorithm
(see Statistical analysis). The kinetic constants Km and Fmax of so-
dium-lithium countertransport activity were determined in erythro-
cytes from 8 normal healthy subjects at the different Li+ loadings
with 150 mmol/1 lithium chloride or 150 mmol/1 lithium bicarbon-
ate. The intra-assay variation for Km was 13.5% (n = 16) and for
rmax 6.3% (n = 16).
Cell volume measurements , f
Volume measurements were carried out with a cell counter CA-
SY®1 (Sch rfe System GmbH, Reutlingen, Germany). Erythr cyte
suspensions were diluted to a final concentration of 30 X 106/1.
The electronic pulse areas related to the particle passage through a
60 μιη diameter capillary tube were analysed. Mean red cell vol-
ume was calculated from the size distribution curve between 4.0
and 6.0 μιη cell diameter. Triplicate measurements were performed
in 0.04 mol/1 phosphate/saline buffer, pH 7.4 at room temperature.
Statistical analysis
Results with a normal distribution are expressed as mean ± SD.
The normality was tested by the Kolmogorov-Smirnov test. The
significance of differences between two groups was assayed using
the Student's t-test. Ρ values (two-tailed) < 0.05 were considered
statistically significant. Non-linear fitting of the Michaelis-Menten
curve was performed by the computer software "SigmaPlot for
Windows" (Jandel Scientific GmbH, Erkrath, Germany). Non-lin-
ear curve fit uses the Marquardt-Levenberg algorithm to find the
coefficients Km and ^max. This algorithm seeks the values of
parameters that minimize the sum of the squared differences be-
tween the values of the observed and predicted values of the depen-
dent variable.
Results
The relationship between sodium-lithium countertrans-
port activity and external sodium concentration for the
calculation of the Michaelis constant and maximum
velocity are shown in figure 1. The kinetics of Li+ efflux
from erythrocytes of all healthy subjects studied, ob-
tained with the two loading procedures, are demon-
50 100 150 200
External [Na*] [mmol/l]
250
Fig. 1 Relationship between sodium-lithium countertransport ac-
tivity« and external sodium concentration of red blood cells after
loading with 150 mmol/1 LiCl (O) or 150 mmol/1 LiHCO3 (·).
The kinetic experiments were fun in duplicate, and each data point
represents the mean ± SD of 8 individual blood samples.
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strated in table 1. Sodium-lithium countertransport activ-
ity did not significantly differ between both loading pro-
cedures. Also, both the Michaelis constant and the maxi-
mum velocity were the same in erythrocytes loaded with
lithium chloride or with lithium bicarbonate. Table 1 fur-
ther shows that the intracellular Li+ content significantly
increased when lithium chloride was replaced by lithium
bicarbonate. Osinolalities in the efflux media containing
200 and 250 mmol/1 NaCl (tab. 2) were somewhat higher
than in the other solutions. However, as shown in table
2, increase of the osmolality in those solutions resulted
in a negligible shrinking of erythrocytes, not exceeding
2.2%.
Loading of the erythrocytes in LiHCO3 was much faster
than in LiCl medium, so that the intracellular Li+ con-
centrations given in table 1 were attained within 15 min,
Tab. 1 Influence on erythrocyte sodium-lithium countertransport
kinetics of different counteranions in Li"1"-loading medium. Eight
normal healthy subjects were used for sodium-lithium
countertransport measurements (mean ± SD).
LiCl LiHCO3
150 mmol/1 150 mmol/1
Sodium-lithium
countertransport activity
[mmol/h X 1 cells]




0.168 ± 0.062 0.165 ± 0.067
0.336 ± 0.089 0.299 ± 0.070
136 ± 27 127 ± 40
7.0 ± 1.41 8.9 ± 1.5
1 p < 0.05 vs. lithium bicarbonate
compared with 180 min with the LiCl method (fig. 2).
The increase of Li4" concentration in red cells was nearly
linear with time. Thus, saturation was not achieved un-
der these conditions. The rates of both Na"'"-induced Li+
efflux (release into NaCl) and the spontaneous Na+-in-
dependent release (release into KC1) were nearly equal
after loading the erythrocytes in lithium bicarbonate or
lithium chloride medium. The values for sodium-lithium
countertransport activity, maximum velocity and Mi-
chaelis constant were not significantly influenced by the
method used for their determination (p > 0.1), as de-
monstrated by the straight lines in figure 3.
Discussion
Discrepant findings have been reported in the literature
with respect to the maximal activity and kinetic con-
stants Km and Kmax of the erythrocyte sodium-lithium
countertransport activity (9). This might be explained by
either the metabolic status of the patients investigated,
different assay methodologies or the use of an insuffi-
ciently high sodium concentration for their correct deter-
mination. Canessa et al. (9) have recently emphasized
the importance of achieving sufficiently high intracellu-
lar Li+ concentrations in order to ensure accurate mea-
surement of sodium-lithium countertransport activity.
Duhm & Becker (6) investigated the Na+-dependent Li+
transport across the human red cell membrane. More-
over, the mechanisms that lead to increased sodium-lith-
ium countertransport activity in various disease condi-
tions seem to be different, e. g. in hypertension the Km
is low, whereas in type I diabetes Kmax is increased (10,
13). It is now clear that there are no significant differ-
ences in the maximal sodium-lithium countertransport
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1 Results obtained with two different samples
2 Referred to erythrocyte volume in isotonic 150 mmol/1 NaCl me-
dium
60 120 180 240
Loading time [min]
Fig. 2 Effect of the loading procedure on the time dependence of
Li"1" concentration in human erythrocytes. Loading was performed
with 150 mmol/1 LiCl (O) and 150 mmol/1 LiHCO3 (O) at 37 °C.
Each data point represents the mean ± SD of 5 individual blood
samples.
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0.0 0.1 0.2 0.3
Sodium-lithium countertransport
(LiCI loading) [mmol/h I cells]
0.0 0.1 0.2 0.3
Vmax (LiCI loading)
[mmol/h I cells]
Fig. 3 Comparison of
a) sodium-lithium countertransport activity
b) maximum velocity (^max) and
c) Michaelis constant (Km)
of erythrocytes from 8 normal subjects after loading with either
150 mmol/1 lithium bicarbonate (y-axis) or lithium chloride (x-






0.4 0 50 100 150 200
Km (LiCI loading) [mmol/l]
a)y = 1.02X- 0.007; r = 0.948
b) y = 0.84x - 0.027; r = 0.915
c)y = 1.24x - 28.0; r = 0.859
The dotted lines represent the identity of both methods.
activity after loading the erythrocytes in either LiCI or
LiHCO3, indicating that intracellular Li+ concentrations
above 5 mmol/1 allow precise Li+ efflux measurements.
It therefore seems unlikely that Li+ loading with lithium
bicarbonate would affect the sodium-lithium
countertransport activity data reported in non-nephro-
pathic and nephropathic diabetes by Elving et al. (3) or
Jensen et al. (4). In previous studies, employing the
well-characterised LiCI method, we found no significant
differences in the erythrocyte sodium-lithium
countertransport activity between subgroups of normoal-
buminuric and microalbuminuric type I diabetic patients
(11), although their activity was higher than in age-
matched healthy control subjects. In this respect, our
previous results compare well with those of Elving et al.
(3) and Jensen et al. (4).
From the present results we may conclude that LiHCO3
loading of erythrocytes results in a reliable and conve-
nient method for measuring the sodium-lithium
countertransport activity of erythrocytes. The main ad-
vantage is that under these conditions high intracellular
Li+ concentrations can be obtained, and much more
rapidly than with LiCI loading, thereby minimising al-
terations of the cell membranes that may occur during
lengthy incubations. Since the loading capacity of the
erythrocytes is high in the presence of LiHCO3, the
loading time ought to be carefully controlled and strictly
limited. LiHCO3 loading considerably shortens the time
needed for an experiment and enables a greater number
of samples to be screened from larger population co-
horts. With respect to the various mechanisms that in-
duce changes of sodium-lithium countertransport activ-
ity in different disease states, it should be emphasised
that determination of Km and Vmax requires carefully
standardised loading conditions. The present loading
procedure rapidly achieves Li+ contents of more than
10 mmol/1 red cells (see fig. 2) and circumvents the use
of nystatin (9), a polyene antibiotic that possibly dis-
rupts the internal electrolyte milieu and causes mem-
brane damage (14, 15).
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